CARLY KNOBLOCH: Open Payments
NPI 1700454287 · BIXBY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,439 in 111 payments from 15 companies in 2025. Trend: 2023 $1,187 · 2024 $1,495 · 2025 $2,439
Food & beverage: $2,324Consulting: $115
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $502 |
| Supernus Pharmaceuticals, Inc. | 20 | $372 |
| Vanda Pharmaceuticals Inc. | 19 | $313 |
| ABBVIE INC. | 30 | $301 |
| Otsuka America Pharmaceutical, Inc. | 6 | $228 |
| Teva Pharmaceuticals USA, Inc. | 7 | $181 |
| Alkermes, Inc. | 6 | $139 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| E.R. Squibb & Sons, L.L.C. | 6 | $110 |
| Madrigal Pharmaceuticals | 3 | $72 |
Products named: Qelbree, INVEGA SUSTENNA, FANAPT, SPRAVATO, REXULTI, VRAYLAR, UZEDY, COBENFY.
Industry payments across OK — which companies pay providers there.
